About Embolic Protection System
Embolic Protection System is a company based in Kalamazoo (United States) founded in 2013. Embolic Protection System has raised $25.75 million across 8 funding rounds. Embolic Protection System offers products and services including Emblok 360. Embolic Protection System operates in a competitive market with competitors including Endologix, Trivascular, Endoron Medical, Shanghai MicroPort Endovascular MedTech and Aptus Endosystems, among others.
- Headquarter Kalamazoo, United States
- SectorsHealthcare
- Email••••••••
- Website emblok.com
- Social LinkedIn
- Total Equity Funding$25.75M (USD)
in 8 rounds
Products & Services of Embolic Protection System
Embolic Protection System offers a comprehensive portfolio of products and services, including Emblok 360.
Captures debris during heart procedures to prevent strokes and organ damage.
Funding Insights of Embolic Protection System
Embolic Protection System has successfully raised a total of $25.75M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $25.75M
- Total Rounds 8
- First Round $335,000
(Jun 2013)
All 8 funding rounds of Embolic Protection System with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2026 | $6M | Series D | – | – | – |
| May 2026 | – | Debt – Conventional | – | – | – |
| Oct 2020 | $269,553 | Series C | – | – | – |
| Dec 2018 | $8M | Series C | – | – | – |
| Jul 2017 | $5M | Series B | – | – | – |
| Apr 2017 | $3.09M | Series A | – | – | – |
| Sep 2014 | $3.06M | Series A | – | – | – |
| Jun 2013 | $335,000 | Seed | – | – | – |
People of Embolic Protection System
11 people are tracked at Embolic Protection System (6 in leadership, 5 in board & advisors).
| Name | Role | Group |
|---|---|---|
R. Kevin Plemmons | CEO | Leadership |
William Merhi | President & CSO | Leadership |
Andrew Kim | Senior Director, Therapy Development | Leadership |
Bradley Brown | Director, Clinical Affairs | Leadership |
Laura Minarsch | VP, Clinical | Leadership |
Carrie Neuberger | VP, Regulatory | Leadership |
Jeffrey Popma | Scientific Advisor | Board & advisors |
Azeem Latib | Scientific Advisor | Board & advisors |
Puneet Khanna | Strategic Advisor | Board & advisors |
Federico De Marco | Scientific Advisor | Board & advisors |
Gary Mccord | Strategic Advisor | Board & advisors |
Complete people profiles for Embolic Protection System
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Embolic Protection System
3 dated milestones of Embolic Protection System across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Embolic Protection System is founded.
- Funding First funding round of $335K.
- Funding Latest funding round, Debt – Conventional,.
Competitors of Embolic Protection System
Embolic Protection System operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endologix, Trivascular, Endoron Medical, Shanghai MicroPort Endovascular MedTech and Aptus Endosystems, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| endologix.com | 1992 | Irvine, United States | – | 488 | Minimally invasive treatments for aortic disorders are developed and manufactured. | |
| trivascular.com | 1998 | Santa Rosa, United States | $260.95M | 307 | Designs and manufactures for endovascular aortic repair equipment | |
| endoronmedical.com | 2019 | Kfar Saba, Israel | $15M | – | Endovascular fixation devices for cardiovascular stent grafts are manufactured. | |
| endovastec.com | 2012 | Shanghai, China | – | – | Medical devices for treating aortic diseases are developed. | |
| aptusendo.com | 2002 | Sunnyvale, United States | $70M | 63 | Endograft anchoring systems for aortic aneurysms are developed. | |
| alturamedical.com | 2008 | Menlo Park, United States | $49.5M | – | Endovascular devices for aortic aneurysms are developed. | |
| medeonbio.com | 2012 | Taipei, Taiwan | – | – | Minimally invasive devices for cardiovascular and laparoscopic procedures are developed. | |
| remonmedical.com | 1997 | Caesarea, Israel | $26M | – | Miniature implants are developed to monitor intra-aneurysm pressure and hemodynamics. | |
| alturainc.com | 2003 | Irvine, United States | $21M | 5 | Stent-grafts are developed for abdominal aortic aneurysm treatment. | |
| jotec.com | 2000 | Hechingen, Germany | – | 451 | Stents and Grafts for Aortic and Peripheral arterial disease |
Detailed competitors of Embolic Protection System
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Embolic Protection System
Complete news archive for Embolic Protection System
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Embolic Protection System
10 companies that operate in the same segment as Embolic Protection System (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | USD 57.22 M | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Embolic Protection System
Embolic Protection System was founded in 2013.
Embolic Protection System is headquartered in Kalamazoo, United States. It is registered at Kalamazoo, Michigan, United States.
Embolic Protection System is a funded company, having raised a total of $25.75M across 8 funding rounds to date. The company's 1st funding round was a Seed of $335K, raised on Jun 2013.
Founded in 2013 and based in Kalamazoo, United States, the company focuses on cardiovascular devices. Embolic protection systems are created to capture material released during left-sided heart procedures, including transcatheter aortic valve replacement (TAVR). Initial European clinical cases were completed successfully in May 2017. As of June 2017, the Emblok system was not available for sale, with operations centered on device innovation to address embolic risks.
Embolic Protection System's top competitors include Endologix, Trivascular and Shanghai MicroPort Endovascular MedTech.
Embolic Protection System offers Emblok 360.